Then, following our arguments to consolidate the hypothesis, Pg-LPS accesses the lymphatic ganglia and the gastric tumor microenvironment, where it binds to TLR4 receptors, increasing the expression of ligands and receptors of the immune checkpoint pathway (PD1/PDL1 axis). The gene discussed is CD274; the disease is gastric neoplasm.